X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
38
PharmaCompass offers a list of Eprosartan Mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Eprosartan Mesylate manufacturer or Eprosartan Mesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Eprosartan Mesylate manufacturer or Eprosartan Mesylate supplier.
PharmaCompass also assists you with knowing the Eprosartan Mesylate API Price utilized in the formulation of products. Eprosartan Mesylate API Price is not always fixed or binding as the Eprosartan Mesylate Price is obtained through a variety of data sources. The Eprosartan Mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Eprosartan Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Eprosartan Mesylate, including repackagers and relabelers. The FDA regulates Eprosartan Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Eprosartan Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Eprosartan Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Eprosartan Mesylate supplier is an individual or a company that provides Eprosartan Mesylate active pharmaceutical ingredient (API) or Eprosartan Mesylate finished formulations upon request. The Eprosartan Mesylate suppliers may include Eprosartan Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Eprosartan Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Eprosartan Mesylate DMF (Drug Master File) is a document detailing the whole manufacturing process of Eprosartan Mesylate active pharmaceutical ingredient (API) in detail. Different forms of Eprosartan Mesylate DMFs exist exist since differing nations have different regulations, such as Eprosartan Mesylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Eprosartan Mesylate DMF submitted to regulatory agencies in the US is known as a USDMF. Eprosartan Mesylate USDMF includes data on Eprosartan Mesylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Eprosartan Mesylate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Eprosartan Mesylate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Eprosartan Mesylate Drug Master File in Korea (Eprosartan Mesylate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Eprosartan Mesylate. The MFDS reviews the Eprosartan Mesylate KDMF as part of the drug registration process and uses the information provided in the Eprosartan Mesylate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Eprosartan Mesylate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Eprosartan Mesylate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Eprosartan Mesylate suppliers with KDMF on PharmaCompass.
A Eprosartan Mesylate written confirmation (Eprosartan Mesylate WC) is an official document issued by a regulatory agency to a Eprosartan Mesylate manufacturer, verifying that the manufacturing facility of a Eprosartan Mesylate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Eprosartan Mesylate APIs or Eprosartan Mesylate finished pharmaceutical products to another nation, regulatory agencies frequently require a Eprosartan Mesylate WC (written confirmation) as part of the regulatory process.
click here to find a list of Eprosartan Mesylate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Eprosartan Mesylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Eprosartan Mesylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Eprosartan Mesylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Eprosartan Mesylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Eprosartan Mesylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Eprosartan Mesylate suppliers with NDC on PharmaCompass.
Eprosartan Mesylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Eprosartan Mesylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Eprosartan Mesylate GMP manufacturer or Eprosartan Mesylate GMP API supplier for your needs.
A Eprosartan Mesylate CoA (Certificate of Analysis) is a formal document that attests to Eprosartan Mesylate's compliance with Eprosartan Mesylate specifications and serves as a tool for batch-level quality control.
Eprosartan Mesylate CoA mostly includes findings from lab analyses of a specific batch. For each Eprosartan Mesylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Eprosartan Mesylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Eprosartan Mesylate EP), Eprosartan Mesylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Eprosartan Mesylate USP).
Market Place
